Metraipolis › archive › dc_afbee4c99760

Pharmacological profiling of intravenous MP-04: sustained NAD+ augmentation, immune modulation, and renal protection in preclinical models — Europe PMC PMID:42358367

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42358367
DOI
10.3389/fphar.2026.1832979
License (as archived)
solo-consultazione
Archived
2026-10-31T14:37:53.243Z
SHA-256 of the archived text
a74ce946000a20ec63fe3ba5067bada4e06be171f5245556570ffd1e1b422e43
Stable URL of this page
https://metraipolis.com/documento/dc_afbee4c99760

How to cite

Pharmacological profiling of intravenous MP-04: sustained NAD+ augmentation, immune modulation, and renal protection in preclinical models — Europe PMC PMID:42358367 — Europe PMC (en), https://europepmc.org/article/MED/42358367 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_afbee4c99760 (Metraipolis archive dc_afbee4c99760, sha256 a74ce946000a20ec63fe3ba5067bada4e06be171f5245556570ffd1e1b422e43)
BibTeX
@misc{dcafbee4c99760,
  title = {Pharmacological profiling of intravenous MP-04: sustained NAD+ augmentation, immune modulation, and renal protection in preclinical models — Europe PMC PMID:42358367},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42358367},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_afbee4c99760; sha256 a74ce946000a20ec63fe3ba5067bada4e06be171f5245556570ffd1e1b422e43},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42358367. Agents can read the archived copy with the MCP tool read_document.